These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The prostate specific antigen: what can we learn from the American experience?]. Zhao XJ Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833 [No Abstract] [Full Text] [Related]
3. Stats & facts. Prostate cancer in the gender-specific scheme of things. Manag Care Interface; 2000 Jul; 13(7):38-9. PubMed ID: 11183927 [No Abstract] [Full Text] [Related]
4. Economic evaluation of prostate cancer screening with prostate-specific antigen. Imamura T; Yasunaga H Int J Urol; 2008 Apr; 15(4):285-8. PubMed ID: 18380812 [TBL] [Abstract][Full Text] [Related]
5. Re: Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability. Etzioni RD; Ankerst DP; Thompson IM J Natl Cancer Inst; 2007 Mar; 99(6):489-90; author reply 490. PubMed ID: 17374841 [No Abstract] [Full Text] [Related]
6. Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. Moul JW; Sun L; Hotaling JM; Fitzsimons NJ; Polascik TJ; Robertson CN; Dahm P; Anscher MS; Mouraviev V; Pappas PA; Albala DM J Urol; 2007 Feb; 177(2):499-503; discussion 503-4. PubMed ID: 17222618 [TBL] [Abstract][Full Text] [Related]
7. Role of free prostate-specific antigen measurement in prostate-specific antigen screening for prostate cancer. Johnson L Clin Prostate Cancer; 2002 Dec; 1(3):142-4. PubMed ID: 15046688 [No Abstract] [Full Text] [Related]
8. Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective. Hayes JH; Barry MJ; Kantoff PW; Stahl JE BJU Int; 2007 Sep; 100(3):486-8. PubMed ID: 17669139 [No Abstract] [Full Text] [Related]
9. Prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective. Kobayashi T; Goto R; Ito K; Mitsumori K Eur J Surg Oncol; 2007 Aug; 33(6):783-9. PubMed ID: 17408910 [TBL] [Abstract][Full Text] [Related]
10. Prostate cancer screening; is this a teachable moment? Brawley OW J Natl Cancer Inst; 2009 Oct; 101(19):1295-7. PubMed ID: 19720970 [No Abstract] [Full Text] [Related]
11. Screening for prostate cancer: recommendations and rationale. Berg AO; Am J Nurs; 2003 Mar; 103(3):107-10; discussion 111. PubMed ID: 12626949 [No Abstract] [Full Text] [Related]
12. Is the era of prostate-specific antigen over? Djavan B; Rocco B; Stangelberger A; De Cobelli O; Marberger M BJU Int; 2007 Jul; 100 Suppl 2():8-10. PubMed ID: 17594349 [No Abstract] [Full Text] [Related]
13. Using predictive value, sensitivity and specificity to interpret laboratory tests: PSA for the diagnosis of prostate cancer. Ashley T J Insur Med; 2005; 37(4):261-3. PubMed ID: 16459948 [TBL] [Abstract][Full Text] [Related]
14. Is an improved PSA screening test in sight? Savage L J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529 [No Abstract] [Full Text] [Related]
15. Application of prostate-specific antigen in prostate cancer. Liang SL MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558 [No Abstract] [Full Text] [Related]
16. Prostate-specific antigen testing. Should we recommend it? Hickey J Can Fam Physician; 2003 Mar; 49():303-4. PubMed ID: 12675542 [No Abstract] [Full Text] [Related]
17. Prostate-specific antigen and prostate cancer prognosis. Church TR J Natl Cancer Inst; 2006 Nov; 98(21):1509-10. PubMed ID: 17077347 [No Abstract] [Full Text] [Related]
18. [Present-day possibilities of prostate cancer screening in patients with benign prostatic hyperplasia before and after surgical treatment]. Pushkar' DIu; Rasner PI; Skobelev PP Urologiia; 2001; (6):48-54. PubMed ID: 11785083 [No Abstract] [Full Text] [Related]
19. Re: Is a screening interval of every 4 years for prostate cancer acceptable? Roobol MJ; Schröder FH J Natl Cancer Inst; 2008 Feb; 100(3):222; author reply 223-4. PubMed ID: 18230797 [No Abstract] [Full Text] [Related]
20. Screening for prostate cancer: current recommendations. Wilson SS; Crawford ED Urol Clin North Am; 2004 May; 31(2):219-26. PubMed ID: 15123402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]